The subsequent research also shows that EVs-EphA2, which promotes the proliferation, invasion, and migration of bladder cancer cells, exhibits strong diagnostic performance, with a sensitivity of 61.1% and a specificity of 97.2% (294). This evidence concerns the gene EPHA2 and urinary bladder carcinoma.